Trial Profile
A clinical study for Neoadjuvant Chemotherapy using apatinib plus cisplatin and capecitabine in local advanced gastric cancer
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2018
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Rivoceranib (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 28 Sep 2018 New trial record